scispace - formally typeset
G

Gigliola Sica

Researcher at Catholic University of the Sacred Heart

Publications -  125
Citations -  2857

Gigliola Sica is an academic researcher from Catholic University of the Sacred Heart. The author has contributed to research in topics: Receptor & Cancer cell. The author has an hindex of 25, co-authored 124 publications receiving 2508 citations. Previous affiliations of Gigliola Sica include Agostino Gemelli University Polyclinic & The Catholic University of America.

Papers
More filters
Journal ArticleDOI

Local overexpression of V1a-vasopressin receptor enhances regeneration in tumor necrosis factor-induced muscle atrophy.

Alessandra Costa, +6 more
- 20 May 2014 - 
TL;DR: A novel in vivo role for AVP-dependent pathways is highlighted, which may represent an interesting strategy to counteract muscle decline in aging or in muscular pathologies.
Journal ArticleDOI

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial

Silvia Laura Bosello, +7 more
- 25 Mar 2010 - 
TL;DR: Anti-CD20 treatment has been well tolerated and SSc patients experienced an improvement of the skin score and of clinical symptoms and the clear fall in IL-6 levels could contribute to the skin fibrosis improvement, while the presence of B cells in the skin seems to be irrelevant with respect to the outcome.
Journal ArticleDOI

Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue

Alessio D’Alessio, +3 more
- 03 Apr 2019 - 
TL;DR: The aim of this review is to recapitulate the pathological features of GBM and of the peritumoral region associated with progression and recurrence and to suggest new immunotherapeutic strategies.
Journal ArticleDOI

Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness

Cristiana Angelucci, +12 more
- 10 Dec 2012 - 
TL;DR: In this paper, the authors investigated whether the crosstalk between malignant cells and the stromal microenvironment heavily influence tumor progression by co-culturing mammary cancer cells exhibiting different degrees of metastatic potential (MDA-MB-231>MCF-7).
Journal ArticleDOI

Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study.

Francesco Recchia, +5 more
- 01 Apr 2002 - 
TL;DR: The data show that the addition of goserelin to adjuvant therapy of premenopausal patients with early breast cancer is well tolerated and protects long-term ovarian function.